The perfection of apoE-mimetic drugs [22-31] for AD may well have a beneficial side effect of yielding compounds that might be also helpful for mitigating temporal lobe and hippocampal damage in patients with TLE. This evidence concerns the gene APOE and Alzheimer disease.